Name | GPR65 agonist |
---|---|
Synonyms |
3-[(2,4-Dichlorobenzyl)sulfanyl]-1,6-dimethyl-1H-pyridazino[4,5-e][1,3,4]thiadiazin-5(6H)-one
1H-Pyridazino[4,5-e][1,3,4]thiadiazin-5(6H)-one, 3-[[(2,4-dichlorophenyl)methyl]thio]-1,6-dimethyl- 3-[(2,4-dichlorobenzyl)thio]-1,6-dimethyl-5,6-dihydro-1H-pyridazino[4,5-e][1,3,4]thiadiazin-5-one MFCD00098495 |
Description | BTB09089 is a T cell death-associated gene 8 (TDAG8/GPR65) specific agonist. BTB09089 increases TDAG8 expression and regulates the cytokine production of T cells and macrophages[1]. |
---|---|
Related Catalog | |
Target |
TDAG8/GPR65[1] |
In Vitro | BTB09089 (0-18 μM; 30 min) 显著增加瞬时表达 hTDAG8 和 mTDAG8 的 HEK293 细胞中 cAMP 的积累,但在对照 HEK293 细胞中无明显增加。BTB09089 不增加表达 hGPR4 的 HEK293 细胞中 cAMP 的积累,也不增加表达 hOGR1 的 HEK293 细胞中肌醇磷酸盐的积累[1]。 BTB09089 (0-18 μM; 30 min) 在 pH 7.0-7.9 时显著地以剂量依赖的方式增强 cAMP 的积累,但在 pH 6.5 时则没有[1]。 BTB09089 (1-5 μM; 20 h) 以剂量依赖的方式抑制 WT 小鼠脾细胞中 IL-2 的产生,但不抑制 TDAG8 KO 小鼠 IL-2,且不影响细胞活力[1]。 BTB09089 (1-5 μM; 18 h) 抑制 LPS (HY-D1056) 刺激的 TNF-α 和 IL-6 的产生,并增强 LPS 刺激的硫酰乙酯诱导的腹膜渗出细胞 (TG-PEC) 中 IL-10 的产生[1]。 |
In Vivo | BTB09089 (5-20 μM, 8 μL; i.c.v.; 6 hours prior to MCAO) 减少大鼠脑缺血再灌注损伤[2]。 Animal Model: Adult male SD rats (270-280 g), middle cerebral artery occlusion (MCAO) model[2] Dosage: 5, 10 and 20 μM, 8 μL Administration: Intracerebroventricular injection, six hours prior to MCAO Result: Up-regulated TDAG8 and Bcl-2 expression and down-regulated cleaved caspase-3 expression, while the infarction volume was reduced, and neurological deficits were ameliorated 24 and 72 h after MCAO. |
References |
Density | 1.6±0.1 g/cm3 |
---|---|
Boiling Point | 500.6±60.0 °C at 760 mmHg |
Molecular Formula | C14H12Cl2N4OS2 |
Molecular Weight | 387.307 |
Flash Point | 256.6±32.9 °C |
Exact Mass | 385.982971 |
LogP | 1.82 |
Vapour Pressure | 0.0±1.3 mmHg at 25°C |
Index of Refraction | 1.733 |